Augurex Life Sciences
Vancouver
About Augurex Life Sciences
Augurex provides biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, who, when identified, can be promptly treated. Their approach has revealed research avenues into multiple autoimmune disease applications across the product portfolio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $726.0K
- Last round: Grant (Mar 2023)
- Website: augurex.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/augurex-life-sciences-43854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.